Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors

ObjectivesGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare but have been increasing in incidence. Limited data on the long-term outcomes of patients with these tumors are available.MethodsIn this study, we used population-based data from the National Cancer Institute to assess long-t